logo
logo
Sign in

Western Blotting Market - Growth Strategy Adopted By Top Players

avatar
Sasha Sharma
Western Blotting Market - Growth Strategy Adopted By Top Players

According to research report the western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).


New product launches was the major growth strategy adopted by players in the western blotting market. The western blotting market is dominated by Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and GE Healthcare (U.S.). These players jointly accounted for approximately 80% of the market in 2016. Other players having significant presence in this market include Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).).


Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711
Bio-Rad Laboratories, Inc. is the leading player in the western blotting market. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company serves the fields of life science research, healthcare, and analytical chemistry with its innovative products and services. The company’s leading position in the market can be attributed to its wide customer base. Bio-Rad, with its 8,000 employees (as of 2015), serves a wide and diversified customer base that includes universities and research institutes, supporting about 150,000 scientists in the U.S.; companies operating in the pharmaceutical, biotechnology, chemical, and food industries; diagnostic manufacturers; and commercial laboratories and hospitals. Bio-Rad strategically focuses on company acquisitions and investments in companies with complementary technologies and product portfolios. For instance, in January 2013, Bio-Rad Laboratories acquired AbD Serotec (U.S.), a manufacturer of antibodies, kits, and accessories.


Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711
GE Healthcare is another major company in the western blotting market. GE Healthcare manufactures and supplies products and services in the fields of medical diagnostics, medical imaging and information technologies, drug discovery, and patient monitoring systems. Over the years, the company has launched various innovative and differentiated products. For instance, in September 2014, GE Healthcare launched Amersham WB system, a fully integrated fluorescence detection system, for western blotting and SDS-PAGE of proteins. In addition, in October 2013, GE Healthcare launched a new PVDF 0.2 ìm membrane, Amersham Hybond 0.2, specifically for chemiluminescence western blotting of smaller peptides and proteins. The introduction of such innovative products has helped the company to be a leading player in the western blotting market.


To know about the assumptions considered for the study, download the pdf brochure

collect
0
avatar
Sasha Sharma
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more